AtriCure Q1 revenue beats estimates, co raises 2026 outlook

AtriCure

05/05/2026 21:11

Overview

U.S. surgical device maker's Q1 revenue rose 14%, slightly beating analyst expectations

Adjusted EBITDA for Q1 grew 95% and beat analyst expectations

Company says U.S. revenue growth driven by AtriClip and cryoSPHERE product adoption

Outlook

AtriCure projects 2026 revenue of $600 mln to $610 mln

Company expects 2026 adjusted EBITDA of $80 mln to $82 mln

AtriCure forecasts 2026 adjusted EPS between $0.00 and $0.04

Result Drivers

PRODUCT ADOPTION - Co said U.S. revenue growth was driven by increased adoption of AtriClip FLEX-Mini, cryoSPHERE MAX, EnCompass clamp, and AtriClip PRO-Mini devices

INTERNATIONAL GROWTH - Co said international revenue rose due to growth across most direct markets in appendage management, open ablation, and pain management

GROSS MARGIN IMPROVEMENT - Co attributed higher gross margin to favorable product and geographic mix

Company press release: ID:nBw5NtVCJa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Slight Beat*
$141.20 mln
$139.81 mln (9 Analysts)
Q1 Adjusted EBITDA
Beat
$17.10 mln
$14.64 mln (7 Analysts)
Q1 Gross Margin
77.40%
Q1 Gross Profit
$109.30 mln
Q1 Operating Income
$526,000


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for AtriCure Inc is $50.00, about 73.7% above its May 4 closing price of $28.78

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)